Bone Marrow Concentrate (BMC)
-
Biologics
Royal Biologics Announces FDA 510K Approval and U.S. Commercial Launch of the MAXX™-BMC Bone Marrow Aspirate Concentration System
June 1, 2022 – OrthoSpineNews – Royal Biologics (Hackensack, NJ) a company specializing on Advanced Cellular Technologies & Enhanced Autologous…
Read More » -
Biologics
Published Regenexx Research, Involving Stem Cells And Platelets, Shows Promise For Treating Osteoarthritis Of The Knee
BROOMFIELD, Colo., Dec, 21, 2018 /PRNewswire/ — New research from Regenexx®, which provides advanced interventional orthobiologics, shows greater potential for treating…
Read More »